Author
BISCHOFF-FERARRI, HEIKE - Jean Mayer Human Nutrition Research Center On Aging At Tufts University | |
ORAV, E JOHN - Harvard School Of Public Health | |
WILLETT, WALTER - Harvard School Of Public Health | |
DAWSON-HUGHES, BESS - Jean Mayer Human Nutrition Research Center On Aging At Tufts University |
Submitted to: Lancet Diabetes Endocrinology
Publication Type: Other Publication Acceptance Date: 3/17/2014 Publication Date: N/A Citation: N/A Interpretive Summary: Technical Abstract: Bolland and colleagues performed a meta-analysis of randomized, controlled trials and concluded that vitamin D is ineffective in lowering risk of fracture, cancer, vascular disease, and mortality. While we agree that this analysis addresses an important question about the efficacy of vitamin D using novel and technically correct analytical methods, we are concerned about two aspects of their approach which may affect the scientific validity of their conclusions. Bolland and colleagues have declared their meta-analysis to be the gold standard of evidence and that incoming new trial data simply could not change the balance of evidence against vitamin D; however, we disagree with that conclusion because of their questionable selection of studies, their requirement of a stringent level of clinical improvement, and, importantly, the inherent limitations of the currently available evidence. Given the limited risk and cost of vitamin D supplementation, we believe that it is too early to recommend the cessation of trials and certainly too early to stop treatment with vitamin D. |